Hepatitis B vaccination: Myths and controversies

Indian Journal of Pediatrics

Volumn 70, Issue 6, 2003, Pages 499-502

  Mittal, S K ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Hepatitis B; Perinatal transmission; Prevalence

Indexed keywords

HEPATITIS B VACCINE;

CHRONIC LIVER DISEASE; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HUMAN; HUMAN CELL; INFECTION RISK; PREVALENCE; RECOMBINANT DNA TECHNOLOGY; VACCINATION; VERTICAL TRANSMISSION; VIRUS CARRIER;

EID: 0037929821     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02723142     Document Type: Conference Paper

References (11)

1. Mittal SK, Yadav S, Desai AB. Seventh EPI vaccine: MMR or Hepatitis B?. Pediatr Today 1992; 33-36.
2. Mittal SK, Aggarwal V. Hepatitis B vaccination in the Expanded Programme of Immunization. Trop Gastro 1996; 17: 188-189.
3. Mittal SK, Rao S, Rastogi A, Aggarwal V, Kumari S. Hepatitis B - Potential of perinatal transmission in India. Trop Gastroenterology 1996, 17: 190-192.
4. Mittal SK. Hepatitis B Vaccination in the EPI: Is it required. Indian J Pediatr 2001.
5. Jain V. Role of vertical and horizontal transmission of hepatitis B in early childhood. Thesis submitted to the University of Delhi for MD. Pediatrics, 2000.
6. Mittal SK, Rao S, Kumari S, Agarwal V, Prakash C, Tirupuram S. Simultaneous administration of hepatitis B vaccine with other EPI vaccines. Indian J Pediatr 1994; 61(2): 183-188.
7. Mittal SK, Kumar N. Optimising Hepatitis B vaccine use in India. Pediatr Today 1998; 1: 35-43.
8. Jain Ajay, Ramji S, Mittal SK. Efficacy and feasibility of incorporating Hepatitis B vaccine in the EPI at 0,6 weeks and 9 months of age (Under preparation).
9. Lodha R, Jain Y, Anand K, Kabra SK, Pandav CS. Hepatitis B in India: A review of disease epidemiology. Ind Pediatr 2001; 38: 1318-1325.
10. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Transmission of Hepatitis B in India. J Med Virology 1987; 21: 137-145.
11. Aggarwal R, Ghoshal UC, Naik SR. Assessment of cost effectiveness of universal Hepatitis B immunization in a low income country with intermediate endemicity using a Markov model. J Hepatology 2003; 38: 215-222.